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Abstract
Background: There has been substantial research on psychosocial and health care determinants of health disparities in the
United States (US) but less on the role of modifiable risk factors. We estimated the effects of smoking, high blood pressure,
elevated blood glucose, and adiposity on national life expectancy and on disparities in life expectancy and disease-specific
mortality among eight subgroups of the US population (the ‘‘Eight Americas’’) defined on the basis of race and the location
and socioeconomic characteristics of county of residence, in 2005.
Methods and Findings: We combined data from the National Health and Nutrition Examination Survey and the Behavioral
Risk Factor Surveillance System to estimate unbiased risk factor levels for the Eight Americas. We used data from the
National Center for Health Statistics to estimate age–sex–disease-specific number of deaths in 2005. We used systematic
reviews and meta-analyses of epidemiologic studies to obtain risk factor effect sizes for disease-specific mortality. We used
epidemiologic methods for multiple risk factors to estimate the effects of current exposure to these risk factors on death
rates, and life table methods to estimate effects on life expectancy. Asians had the lowest mean body mass index, fasting
plasma glucose, and smoking; whites had the lowest systolic blood pressure (SBP). SBP was highest in blacks, especially in
the rural South—5–7 mmHg higher than whites. The other three risk factors were highest in Western Native Americans,
Southern low-income rural blacks, and/or low-income whites in Appalachia and the Mississippi Valley. Nationally, these four
risk factors reduced life expectancy at birth in 2005 by an estimated 4.9 y in men and 4.1 y in women. Life expectancy
effects were smallest in Asians (M, 4.1 y; F, 3.6 y) and largest in Southern rural blacks (M, 6.7 y; F, 5.7 y). Standard deviation
of life expectancies in the Eight Americas would decline by 0.50 y (18%) in men and 0.45 y (21%) in women if these risks had
been reduced to optimal levels. Disparities in the probabilities of dying from cardiovascular diseases and diabetes at
different ages would decline by 69%–80%; the corresponding reduction for probabilities of dying from cancers would be
29%–50%. Individually, smoking and high blood pressure had the largest effect on life expectancy disparities.
Conclusions: Disparities in smoking, blood pressure, blood glucose, and adiposity explain a significant proportion of
disparities in mortality from cardiovascular diseases and cancers, and some of the life expectancy disparities in the US.
Please see later in the article for the Editors’ Summary.
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Life expectancy disparities in the United States (US) are
extremely large and have persisted over time [1–6]. For example,
black men and women in the US live 6.3 and 4.5 years,
respectively, less than their white counterparts [3]. The life
expectancy gap between the counties with the highest and lowest
life expectancies is about 18.4 years for men and 14.3 years for
women, with even larger disparities for race–county combinations
[1,2]. Previous research has shown that disparities in mortality
from chronic diseases, especially cardiovascular diseases (CVD),
cancers, and diabetes, are the main determinants of life expectancy
disparities by race and by county in the US, with additional effects
from HIV/AIDS and homicide in men [1–3,7,8]. Disparities for
diseases related to smoking and alcohol use, and those related to
health care access, also seem to be determinants of mortality
disparities by socioeconomic status in European countries [9].
Preventable risk factors such as smoking, elevated blood
pressure, and adiposity are responsible for hundreds of thousands
of chronic disease deaths in the US [10]. Data from health
examination and interview surveys show that there are large
differentials by race, state of residence, and socioeconomic status
in exposure to these risk factors [7,11–17]. To ensure that
prevention policies and programs not only improve average health
status but also reduce disparities, it is essential to know how much
the observed disparities in risk factor exposure contribute to
disparities in mortality and life expectancy. The effects of
modifiable risk factors on US mortality disparities have also been
analyzed in selected cohorts [18–20]. National analysis in the US
has been limited to the effects of smoking on male mortality
disparities or to the effects of multiple risk factors on disparities in
self-reported health status and disease diagnosis [21–23]. There is
currently no estimate of the effects of multiple modifiable risk
factors on life expectancy disparities in the US. This is in contrast
to the extensive research on the socioeconomic and health care
determinants of health disparities [24–29]. This lack of evidence
limits the ability to assess how risk factor interventions are
expected to affect health disparities above and beyond their
aggregate national impacts, and what combination of risk factor
interventions may be used, in combination with social and health
care policies, to reduce mortality disparities.
We used multiple national data sources on risk factor exposures
and epidemiologic evidence on their mortality effects to quantify
how much four major chronic disease risk factors affect life
expectancy disparities in the US, individually and in combination.
Specifically, we examined how differentials in current risk factor
exposure account for disparities in life expectancy and disease-
specific mortality among population subgroups based on race and
the location and socioeconomic characteristics of county of
residence.
Methods
Population Subgroups
Previous analyses have demonstrated that grouping the US
population by a combination of race and county characteristics
(region, median county income by race, rural versus urban status
of a county, and urban homicide risk) encompass a relatively large
part of the overall observed race–county life expectancy
disparities, while keeping the number of subgroups tractable and
their definitions constant over time [1,2]. Based on these findings,
we used eight subgroups of the US race–county combinations,
referred to as the Eight Americas in a previous work [1] and
defined in Table 1, as our units of analysis. The Eight Americas
also provide sufficient sample size for statistically reliable estimates
of risk factors and disease-specific mortality.
Table 1. Definitions and selected characteristics of the Eight Americas [1].
America General Description
Population
(Millions in 2005)
Per-Capita
Income
Percent Completing
High School Definition
1 Asians 12.2 $21,566 80% Asians living in counties in which Pacific Islanders make
up less than 40% of total Asian population
2 Northland low-income
rural whites
3.5 $17,758 83% Whites in the northern plains and Dakotas with 1990
county-level per capita income below $11,775 (national
median for whites) and population density less than
100 persons/km
2
3 Middle America 223 $24,640 84% Allother whites not includedin Americas2 and 4, Asians
not in America 1, and Native Americans not in America 5
4 Low-income whites in
Appalachia and the
Mississippi Valley
17 $16,390 72% Whites in Appalachia and the Mississippi Valley with
1990 county-level per capita income below $11,775
5 Western Native
Americans
1 $10,029 69% Native American populations in the mountain and
plains areas, predominantly on or near reservations
6 Black middle America 25.7 $15,412 75% All other black populations living in counties not
included in Americas 7 and 8
7 Southern low-income
rural blacks
5.9 $10,463 61% Blacks living in counties in the Mississippi Valley and the
Deep South with population density below 100 persons/
km
2, 1990 county-level per capita income below $7,500
(national median for blacks), and total population size
above 1,000 persons (to avoid small numbers)
8 High-risk urban blacks 7.4 $14,800 72% Urban populations of more than 150,000 blacks living in
counties with cumulative probability of homicide death
between 15 and 74 years of age greater than 1.0%
Income per capita and education were calculated for race-county combinations from the 2000 US census.
doi:10.1371/journal.pmed.1000248.t001
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The risk factors in this analysis were four of five leading risk
factors for mortality in the US based on our recent analysis [10]:
smoking, high blood pressure (measured with usual systolic blood
pressure, SBP), high blood glucose (measured with usual fasting
plasma glucose, FPG), and adiposity (measured with body mass
index, BMI). In 2005, smoking was responsible for an estimated
467,000 deaths, high blood pressure 395,000, high BMI 216,000,
and high blood glucose 190,000 [10]. Inadequate/no physical
activity was the fourth leading risk factor but was not included
because the available data were not of sufficient quality to directly
measure or indirectly estimate exposure in the Eight Americas.
We report disparities in life expectancy and probabilities of
death across the Eight Americas using both the population-
weighted standard deviation (SD) of life expectancy and the
difference in life expectancy between the Americas with the
highest and lowest life expectancies.
Calculating Mortality Attributable to Risk Factors
We estimated the number of deaths that would have been
prevented in 2005 if past and current exposure to these risk factors
had been at an alternative (lower) distribution. This can be
interpreted as the excess number of deaths (or excess mortality
rate) caused by the individual- and population-based determinants
that have led to the observed distributions of risk factor exposure.
We conducted all analyses separately by sex and age group (30–44,
45–59, 60–69, 70–79, and 80+ years), and separately for each of
the Eight Americas.
Most chronic diseases are caused by multiple risk factors that act
together, sometimes through overlapping pathways. For example,
some CVD deaths in people who both smoke and have high SBP
may be prevented by reducing either risk factor. Further, the
effects of one risk factor, e.g. BMI, may be mediated partly
through other risks, e.g. SBP and FPG. Therefore, simple addition
of the effects of individual risk factors will generally overestimate
the true combined impact of multiple factors. Our analyses
systematically incorporated multicausality and mediated effects as
described below.
For each America–age–sex unit of analysis, we first calculated
the proportion of disease-specific deaths that would have been
prevented if the exposure to these risks had been reduced to an
alternative (lower) distribution; this metric is known as the
population attributable fraction (PAF). The diseases included in
the analysis were selected on the basis of a review of evidence on
causal associations, with the sources of evidence and list of diseases
with strong or convincing evidence presented in detail elsewhere
[10].
In previous work, we had calculated the PAF using the
distribution of individual risks in the population [10,30] and had
subsequently used a simple relationship to calculate the combined
(joint) PAF for multiple risks [31]. In the current analysis, we used
a computational approach that incorporated two important
features of multiple risk analysis: First, the effects of BMI on
CVD are mediated partly through SBP and FPG, which are also
included in the analysis, with the remainder through other
pathways (e.g., dyslipidemia and inflammation) [32–34]. There-
fore, the combined effects of BMI, SBP, and FPG will be those of
the latter two plus the non-SBP/FPG-mediated effect of BMI.
Data sources for establishing the mediated component of the effect
of BMI on CVD outcomes are described below. The second
feature of multiple risks incorporated into our current analysis is
their correlation, i.e., that some people have higher/lower
exposure to multiple risk factors due to common socioeconomic
or behavioral determinants. It is known that when risk factors are
correlated, the simple approach to estimating PAFs that assumes
independent distributions may be biased [35]. To incorporate risk
factor correlation, we computed the PAF by summing the risks for
individual BRFSS participants, weighted by their sampling
probability (see Text S1 for details).
For each disease causally associated with these risk factors, the
mortality rate attributable to the combined effects of risk factors
was calculated by multiplying the joint PAF with the observed
mortality rate in the corresponding America–age–sex unit of
analysis. To calculate all-cause mortality attributable to risk
factors, we summed the attributable disease-specific mortality rates
in each America–age–sex unit of analysis. Mortality rates from
different diseases can be added because the International
Classification of Disease system assigns each death categorically
to only one underlying disease cause; hence deaths from different
diseases are mutually exclusive and additive.
Calculating the Effects of Risk Factors on Life Expectancy
and Probabilities of Death
We calculated life expectancy for each America using standard
life table methods, and used validated demographic techniques to
estimate the mortality rates in the oldest ages where both
population numbers from census and the number of deaths from
vital registration are less reliable [36,37]. We calculated life tables
for each sex and America using the observed age-specific mortality
rates as well as the mortality rates that would be expected if risk
factor exposures had been at the alternative distribution. The
differences between the two sets of life expectancies measure the
life expectancy gain from having reduced risk factors to the
alternative distribution. Similarly, we used life table methods to
calculate the effects of risk factors on the probability of dying
between the ages of 15 and 60 y (denoted 45Q15) and between the
ages of 60 and 75 y (denoted 15Q60).
Data Sources
Risk factor exposure. National Health and Nutrition
Examination Survey (NHANES) provides measured risk factor
data by race at the national level; Behavioral Risk Factor
Surveillance System (BRFSS) provides subnationally repre-
sentative self-reported data on weight and height, smoking, and
history of diagnosis with hypertension and diabetes. Self-reported
weight and height data may be biased because of intentional
misreporting. For SBP and FPG, respondents may not be aware of
their risk status if they have not had recent health system
encounter; after diagnosis, medication use and lifestyle
modification may lower risk factor level. We used previously
described and validated statistical methods [14–16] to combine
data from NHANES and BRFSS for estimating unbiased risk
factor levels in the BRFSS. BRFSS records could be assigned to
the Eight Americas using race and county identifiers. We pooled
the BRFSS data for 2003 and 2005 in this analysis because these
years included all variables needed for predicting unbiased risk
factor levels as well as county identifiers. County identifiers for
2006 and subsequent years were not available to us.
Disease-specific deaths. The number of deaths by
underlying cause, age and sex in 2005 was obtained from the
National Center for Health Statistics (NCHS), which maintains
records for all deaths in the US. Although the US has automated
(computerized) assignment of an International Classification of
Diseases code for the underlying cause of death, the validity and
comparability of cause of death statistics may be affected at the
time of medical certification, especially for CVD and diabetes
[38–40]. We adjusted for incomparability in cause of death
assignment using previously described methods [38,39]. These
US Risk Factors and Health Disparities
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of death and county of residence. We obtained county identifiers
for all deaths in 2005 through a special request to the NCHS.
Linked mortality follow-up studies in the US have found that
there is differential under- or overestimation of race-specific
mortality rates [5]. This occurs because race is recorded by
individuals or their families in the census and by the certifying
physician or funeral facility on the death certificate. Differential
recording is a potential source of bias in race-specific mortality
rates and life expectancy. Studies using linked data have shown
that this bias may be as much 3% among Asians, which are one of
the Eight Americas. We used the National Mortality Followback
Survey [5] to adjust for this bias in America 1, by age and sex.
There was a corresponding reduction in deaths in America 3, the
group to which Asians are most likely to be misclassified, so that
the total number of deaths in the US remained constant.
Population. We obtained population estimates for 2005 by
age, sex, race, and county of residence from the NCHS. We used
post-enumeration surveys to adjust the population estimates for
under-counting of Asian Americans [5]. The combination of
adjustments for under-reporting of deaths and under-counting of
population in census for Asian-Americans increased the mortality
rate in this group (America 1) by 3%.
Effects of individual risk factors on disease-specific
mortality. We estimated mortality effects for those diseases
for which there was strong or convincing evidence of causal
association, with evidence evaluated in previous work [10]. For
each risk factor and disease we obtained relative risks (RRs) by age
and sex from systematic reviews and meta-analyses of most recent
epidemiologic studies, as described elsewhere [10].
We reviewed the evidence on whether RRs vary by race from
trials and observational studies in the US and other countries
(Table S1). The current evidence indicates that while the absolute
effects (e.g., excess mortality rate) of risk factors vary by race, their
proportional effects (i.e., RR) did not vary appreciably by race and
ethnicity.
Effect of BMI mediated by SBP and FPG. We used a
recent meta-analysis of epidemiologic studies that had estimated
the effect of BMI on CVD that is mediated through SBP and FPG,
and found additional studies (Table S2) that that had not been
included in this meta-analysis. Based on a quantitative overview of
these studies, we estimated that 50% (95% CI 30%–70%) of the
excess risk (RR minus one) for the effect of BMI on CVD was
mediated through SBP and FPG.
Alternative Risk Factor Exposure Distributions
We estimated the effects of risk factors on mortality and life
expectancy in the Eight Americas relative to three different
alternative exposure distributions (Table 2): (1) the lowest observed
exposure in any of the Eight Americas, by age (because this
exposure has been achieved in at least one of the Americas, it
constitutes a feasible alternative); (2) an optimal distribution in
which the hazardous effects of risk factors are minimized, as
described in detail elsewhere [10,41]; and (3) a distribution whose
mean equals current clinical guidelines.
Analyses of Uncertainty
We quantified the uncertainty due to sampling variability using
a simulation approach. In each of 1,000 simulation rounds, for
each America–age–sex analysis unit, we drew (1) a random sample
of the participants in the BRFSS; this sample was drawn with
replacement and the sample size was equal to the original number
of participants with no missing risk factor data (bootstrapping)
[42]); (2) a RR for each disease causally associated with risk factors
from a log-normal distribution whose standard error was from
epidemiologic studies [10]; (3) the proportion of the excess risk of
BMI mediated through SBP and FPG from a normal distribution
with mean of 0.5 and SD of 0.1; and (4) a disease-specific mortality
rate for each disease causally associated with risk factors, with the
distribution of mortality rate obtained as described elsewhere [2].
The 1,000 simulated draws were used to estimate the sampling
uncertainty for mortality and life expectancy impacts of risk
factors.
All analyses were conducted using STATA 10.1 (StataCorp,
Texas, USA). The simulations were run on the Orchestra
Research Computing Custer supported by the Harvard Medical
School Research Information Technology Group.
Results
Disparities in Risk Factor Exposure
There were substantial disparities in exposure to these four risk
factorsacrossthe EightAmericas(Table 3).Asian Americanmenand
women (America 1) had the lowest BMI, FPG, and smoking, while
whites had the lowest mean SBP. The highest SBP was observed in
blacks, especially those in the rural South (America 7), whose mean
SBP was 5–7 mmHg higher than whites in different age and sex
groups. The highest mean BMI was in western Native American men
(age-standardized mean 30.0 versus 26.7 kg/m
2 in Asians) and
Southern low-income rural black women (age-standardized mean
33.9 versus 26.2 kg/m
2 in Asians). Mean FPG across the Eight
Americas generally followed the same pattern as BMI. Western
Native Americans (America 5) and low-income whites in the
Appalachia and Mississippi Valley (America 4) had the highest
smoking prevalence, with about 30% of men and women currently
smoking. Smoking prevalence was also relatively high among blacks.
Effects of Risk Factors on Life Expectancy in the Eight
Americas
In 2005, national life expectancy in the US was 75.1 y for men
and 80.3 for women. Asians had the highest life expectancy at
birth in the Eight Americas, reaching 86.8 y for women and 82.3
for men (Figure 1); these are, respectively, about 1 and 2 y higher
than the highest life expectancies in the world (Japan for women
and San Marino for men). Blacks had the lowest life expectancy in
both men (68.1 y in the rural South and high-risk urban areas) and
women (74.9 y in the rural South). There was a declining life
expectancy gradient from America 1 to Americas 7 and 8, with the
14- and 12-y gaps in men and women equal to those observed
between middle- and high-income countries worldwide [1]. The
population-weighted SD of the Eight Americas life expectancies
was 2.7 y for men and 2.1 y for women.
Nationally, the four preventable risk factors have lowered life
expectancy by an estimated 4.9 y for men and by 4.1 y for
women. Had these four risk factors been reduced to their optimal
distributions in all groups, gains in life expectancy would have
been larger in the Americas with currently low life expectancy,
although there would be benefits in other groups also (Figure 1).
For example, Southern low-income rural black men and women
(America 7) would have gained 6.7 and 5.7 y, respectively, versus
4.1 and 3.6 y in Asians (America 1). The life expectancy benefits
were larger for men than for women in all Americas, except in
western Native Americans (4.6 y for men versus 5.0 for women).
Among whites, the largest gains were in Appalachia and
Mississippi Valley (America 4), where men and women would
gain 5.7 and 4.5 y life expectancy if risk factor exposures were at
optimal levels. Had risk factor levels been at their optimal
distributions in all Americas, the population weighted SD of life
US Risk Factors and Health Disparities
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(21%) in women; life expectancy gaps between the best- and worst-
off Americas would be lowered by 1.9 y (13%; America 1 versus
America 8) in men and 2.0 y (17%; America 1 versus America 7)
in women.
The life expectancy gains under the other two more realistic
alternative exposure distributions were smaller than those under
optimal distributions, by 0.7–1.5 y in different Americas when the
lowest observed exposure by age was used and by 1.0–1.6 y when
the guidelines were met (Figure 1). These more modest risk factor
reductions would nonetheless have larger benefits for those
Americas with currently lower life expectancy, and hence reduce
life expectancy disparities. These alternative risk factor distribu-
tions would lower population-weighted SD by 0.44–0.47 y, about
the same as those expected when risks were lowered to their
optimal levels.
When risk factors were analyzed individually, removing smoking
would have led to the largest gains in life expectancy in men in all
Eight Americas,and inwhiteandNative American women (Table 4).
Smoking reduction alone accounted for 42%–58% of the years
gained by all four risks in men and 12%–46% in women in these
Americas (noting that the effects of individual risk factors on life
expectancy are not additive due to multicausality and competing risk
from other diseases). Lowering blood pressure to its optimal
distribution would have achieved between 27% (men in America 4)
and 69% (women in America 1) of the benefits of all four risk factors.
The largest benefit from any single risk factor among black women
was from lower blood pressure, alone explaining about one-halfof the
life expectancy gain from all four risks (47%–49%). Adiposity was the
second single most important risk factor in black women (40%–48%).
Effects of Risk Factors on Disease-Specific Probabilities of
Death
Western Native Americans (America 5) and low-income blacks
in the rural South (America 7) and high-risk urban areas (America
8) had the highest probability of dying between the ages of 15 to
60 y (45Q15) in the year 2005 (Figures 2 and 3). In these three
Americas, about one out of four men and one out of six women
who survived to age 15 are expected to die before their 60th
birthday (versus 4% for men and 7% for women in America 1).
Most of these deaths were caused by CVD and cancers, except in
Native Americans, among whom injuries, diabetes, liver cirrhosis,
digestive diseases, and alcohol use disorders also contributed
substantially to young and middle-aged deaths. HIV/AIDS
continued to be an important cause of death in young and
middle-aged blacks despite the availability of efficacious treat-
ments. The survival advantage of Asians and whites (except those
in America 4) continued into older ages, with Asians who survive
to their 60th birthday having a 19% (men) and 13% (women)
probability of dying before their 75th birthday (15Q60), versus 44%
and 29% for Southern rural blacks (Figures 2 and 3).
Reducing smoking, SBP, FPG, and BMI to their optimal
distributions would have improved survival in all Eight Americas,
with the largest benefits in those that currently have the highest
probabilities of death. For example, the disparity in male 45Q15
between the highest and the lowest probability of death in 2005
Table 2. Risk factors in this analysis, their exposure metric, lowest observed mean in the Eight Americas, clinical guidelines, and
optimal exposures.
Risk Factor
a
Exposure
Metric (Unit)
Lowest Age-Specific Mean Exposure in
the Eight Americas
Clinical
Guidelines
b
Optimal Exposure
Distribution
c
Tobacco smoking Current and former
smoking (percent)
Age
30–44
45–59
60–69
70–79
80+
Current
7
7
3
3
1
Former
8
9
17
17
14
No smoking No smoking
High blood pressure Systolic blood pressure,
SBP (mmHg)
Age
30–44
45–59
60–69
70–79
80+
Mean
111
d
121
130
134
128
SD
5
9
13
13
10
130 (6.78) [67] 115 (6)
Overweight-obesity (high
body mass index, BMI)
BMI (kg/m
2) Age
30–44
45–59
60–69
70–79
80+
Mean
25.4
26.8
27.4
27.2
25.4
SD
4.1
4.2
2.5
2.8
13.7
25 (1.2) 21 (1)
High blood glucose Fasting plasma glucose,
FPG (mg/dl)
Age
30–44
45–59
60–69
70–79
80+
Mean
89
97
105
102
97
SD
7
13
19
17
15
100 (5.9) [68] 88 (5.2)
aSee a previous national analysis of risk factor effects for a list of disease outcomes causally associated with each risk factor [10].
bThe means (SD) of the normal distribution are reported. We used the threshold used in the recent clinical guidelines as the mean. The SD was estimated using the
coefficient of variation for the optimal exposure distribution of the same risk factor.
cThe epidemiologic evidence for selection of optimal distribution is described in a previous work [10]. The primary criterion was the level to which randomized trials and
observational studies indicate benefits of lowering exposure continue. The mean (SD) of the normal distribution are reported here.
dThe lowest observed mean SBP in this age group was lower than the mean of the optimal distribution, i.e., the level to which benefits of lowering exposure have been
observed in current epidemiologic studies. We did not assign any benefits to exposures lower than the optimal distribution.
doi:10.1371/journal.pmed.1000248.t002
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45Q15 between highest and lowest probability of death would
decline from 0.12 to 0.08 if these risks were at their optimal
distributions. There would also be a reduction in survival
disparities in older adults (15Q60).
The largest disparity effects of these risk factors were on CVD
and diabetes mortality. CVD and diabetes mortality disparities in
different age and sex groups in the optimal risk factor scenario
would be 69%–80% smaller than their current levels. Similarly,
cancer mortality disparities would be 29%–50% lower. Among
cancers, breast, colorectal, and residual lung cancer deaths were
the main source of remaining disparities, with their rates largest
among blacks and in low-income whites in Appalachia and
Mississippi Valley (America 4).
Table 3. Exposure to risk factors by sex and age group in the Eight Americas.
Age–Sex Group America
a
SBP,
mmHg
BMI,
kg/m
2
FPG,
mg/dl
Current
Smoking, %
Former
Smoking, %
Male 30–59 y Asians (America 1) 125 (1.7) 26.6 (0.39) 99 (0.8) 15 (3.5) 23 (4.3)
Northland low-income rural whites
(America 2)
122 (1.0) 28.7 (0.28) 100 (0.4) 24 (2.7) 26 (2.6)
Middle America (America 3) 123 (0.2) 28.6 (0.08) 101 (0.2) 24 (0.6) 27 (0.6)
Low-income whites in Appalachia and
Mississippi Valley (America 4)
122 (0.6) 29.1 (0.19) 102 (0.3) 35 (1.8) 26 (1.5)
Western Native Americans (America 5) 127 (2.7) 30.2 (0.78) 104 (1.2) 33 (6.6) 24 (5.8)
Black middle America (America 6) 128 (1.0) 29.3 (0.32) 102 (0.6) 28 (2.6) 18 (2.2)
Southern low-income rural blacks
(America 7)
129 (1.3) 29.7 (0.44) 104 (1.0) 34 (3.7) 19 (2.7)
High-risk urban blacks (America 8) 129 (1.5) 29 (0.59) 101 (0.8) 31 (4.5) 19 (4.0)
Male $60 y Asians (America 1) 135 (4.4) 27 (0.81) 106 (1.9) 5 (3.5) 35 (11.7)
Northland low-income rural whites
(America 2)
133 (1.2) 28.6 (0.34) 110 (1.0) 11 (2.3) 59 (3.7)
Middle America (America 3) 133 (0.3) 27.9 (0.09) 109 (0.3) 11 (0.6) 56 (1.0)
Low-income whites in Appalachia and
Mississippi Valley (America 4)
133 (0.8) 27.9 (0.21) 110 (0.6) 14 (1.4) 56 (2.2)
Western Native Americans (America 5) 138 (4.0) 29.4 (1.14) 116 (3.6) 21 (9.2) 40 (9.8)
Black middle America (America 6) 138 (2.0) 28.3 (0.52) 112 (1.4) 19 (4.3) 45 (6.1)
Southern low-income rural blacks
(America 7)
140 (2.0) 28.7 (0.57) 113 (1.8) 17 (3.7) 44 (5.6)
High-risk urban blacks (America 8) 138 (2.9) 28 (0.78) 110 (2.1) 21 (5.9) 39 (7.5)
Female 30–59 y Asians (America 1) 119 (1.6) 25.6 (0.48) 93 (0.7) 7 (2.6) 7 (2.2)
Northland rural low-income whites
(America 2)
117 (1.0) 29.2 (0.44) 95 (0.3) 23 (2.3) 22 (2.3)
Middle America (America 3) 117 (0.2) 28.6 (0.1) 96 (0.1) 22 (0.5) 23 (0.5)
Low-income whites in Appalachia and
Mississippi Valley (America 4)
117 (0.5) 30.3 (0.26) 98 (0.3) 32 (1.4) 18 (1.1)
Western Native Americans (America 5) 122 (2.0) 31.1 (0.92) 101 (1.3) 36 (6.2) 14 (3.4)
Black middle America (America 6) 123 (0.8) 32.7 (0.42) 98 (0.5) 22 (1.8) 15 (1.5)
Southern low-income rural blacks
(America 7)
124 (1.1) 34.3 (0.52) 100 (0.7) 19 (2.1) 12 (1.6)
High-risk urban blacks (America 8) 122 (1.3) 32.3 (0.68) 97 (0.6) 24 (3.0) 15 (2.4)
Female $60 y Asians (America 1) 143 (4.8) 27.6 (1.37) 103 (2.4) 3 (2.0) 21 (7.2)
Northland low-income rural whites
(America 2)
139 (1.2) 29.7 (0.39) 104 (0.6) 8 (1.5) 27 (2.7)
Middle America (America 3) 139 (0.3) 28.9 (0.12) 104 (0.2) 11 (0.5) 34 (0.7)
Low-income whites in Appalachia and
Mississippi Valley (America 4)
139 (0.6) 29.2 (0.25) 105 (0.4) 14 (1.1) 26 (1.4)
Western Native Americans (America 5) 140 (3.6) 30.1 (1.79) 108 (2.9) 15 (5.7) 36 (10.1)
Black middle America (America 6) 143 (1.6) 31.9 (0.67) 108 (1.1) 14 (2.7) 27 (3.4)
Southern low-income rural blacks
(America 7)
144 (1.5) 32.7 (0.7) 110 (1.3) 10 (2.4) 20 (3.0)
High-risk urban blacks (America 8) 144 (2.3) 31.0 (0.87) 106 (1.6) 12 (3.2) 32 (5.5)
Table shows mean (standard error) for SBP, BMI, FPG, and prevalence (standard error) for smoking. The lowest and highest mean exposures in each age-sex group are
shown in bold font. Within each age group, exposures are age-standardized to the 2005 US population.
doi:10.1371/journal.pmed.1000248.t003
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Life expectancy disparities in the US, measured in relation to
individual and community characteristics, are enormous by
international standards. The Eight Americas encompass a large
part of US life expectancy disparities, while forming easily
identifiable subgroups of the US population. We have shown that
a small number of preventable risk factors such as smoking, high
blood pressure, elevated blood glucose, and adiposity are the
leading risk factors for mortality in the US [10]. The results from
the current analysis suggest that these risk factors also contribute to
the mortality disparities across the Eight Americas, especially for
CVD and cancers. Therefore, had these risk factors been reduced
to their optimal levels or even to the commonly used guidelines,
Figure 1. Current life expectancy at birth and life expectancy under three alternative risk factor distributions in the Eight Americas
for men and women. See definitions of the Eight Americas in Table 1. The means and 95% confidence intervals for life expectancy under the three
alternative distributions was estimated using simulations as described in Methods. Because the number of simulations was finite, the means may be
slightly different from the numbers reported in Table 4 and the text. This difference is in the order of 0.1% and does not affect our conclusions.
doi:10.1371/journal.pmed.1000248.g001
Table 4. Life expectancy gains (in years) expected by reducing individual risk factors to their optimal distributions.
America
a Sex Overall Gain, y SBP BMI FPG Smoking
National Male 4.9 1.5 (31) 1.3 (26) 0.5 (10) 2.5 (52)
Female 4.1 1.6 (39) 1.3 (31) 0.3 (7) 1.8 (43)
Asians (America 1) Male 4.1 1.5 (38) 1.0 (26) 0.4 (10) 1.7 (42)
Female 3.6 2.5 (69) 0.5 (15) 0.1 (4) 0.4 (12)
Northland low-income rural whites (America 2) Male 4.7 1.4 (29) 1.2 (26) 0.5 (10) 2.4 (51)
Female 3.6 1.4 (39) 1.2 (32) 0.3 (7) 1.4 (39)
Middle America (America 3) Male 4.7 1.4 (30) 1.2 (26) 0.5 (10) 2.4 (52)
Female 4.0 1.4 (37) 1.1 (29) 0.3 (7) 1.8 (45)
Low-income whites in Appalachia and Mississippi
(America 4)
Male 5.7 1.5 (27) 1.5 (26) 0.6 (11) 3.3 (58)
Female 4.5 1.6 (35) 1.4 (32) 0.4 (8) 2.1 (46)
Western Native Americans (America 5) Male 4.6 1.5 (32) 1.6 (34) 0.5 (11) 2.4 (51)
Female 5.0 1.6 (33) 1.8 (36) 0.4 (9) 2.1 (42)
Black middle America (America 6) Male 6.0 2.3 (38) 1.8 (30) 0.6 (11) 2.7 (45)
Female 5.3 2.5 (48) 2.3 (43) 0.5 (10) 1.6 (30)
Southern low-income rural blacks (America 7) Male 6.7 2.6 (40) 2.1 (32) 0.8 (12) 3.1 (46)
Female 5.7 2.8 (49) 2.7 (48) 0.7 (11) 1.5 (26)
High-risk urban blacks (America 8) Male 6.0 2.6 (43) 1.9 (32) 0.6 (10) 2.6 (43)
Female 5.4 2.5 (47) 2.2 (40) 0.4 (8) 1.8 (34)
Numbers in brackets show the gain as % of gain expected if all risk four risk factors are reduced; percents add to more than 100% because of multi-causality and
because life expectancy is affected by competing risk from other diseases.
doi:10.1371/journal.pmed.1000248.t004
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decline in life expectancy disparities. Our conclusions on the role
of these risk factors on life expectancy disparities across the Eight
Americas were not sensitive to the specific disparity metric used
(for a discussion of disparity metrics see [43]).
Analyses of disease-specific probabilities of death identified
injuries, HIV/AIDS (especially for men), and selected noncom-
municable diseases as those that accounted for disparities that
remained after risk factors were reduced to optimal levels. Once
we removed deaths from homicide, road traffic injuries, and HIV/
AIDS in addition to the effects of risk factors, life expectancy
further improved with larger benefits to the Americas that
currently have lower life expectancy, especially for men. For
example, reducing risk factors to their optimal levels and removing
these three medical causes of death increased male life expectancy
in Americas 5, 7, and 8 by 7.3–9.4 y (compared with 4.6–6.7 y
when only risk factors are reduced). Yet even CVD mortality had a
residual gradient, albeit substantially smaller, after four of its most
salient risk factors were removed, with a clear survival advantage
among Asians (Figures 2 and 3). The reasons for this residual
advantage may be risk factors not included in our analysis (e.g.,
lower lipids as a result of dietary composition or use of statins,
psychosocial factors, etc.) or disparities in health care access and
quality of care. These factors could not be estimated in the
BRFSS, but should be the subject of future data collection and
research. Further, the benefits of reducing current exposure occurs
over time and requires additional analysis of time-dependent
effects. Most of the benefits nonetheless seem to occur within
about 5 y for cardiovascular risk factors [44]; even for the effects of
smoking on cancers and chronic respiratory diseases, which have
longer periods of risk reversibility, 75% or more of the benefits of
cessation occur by about 15 y [45].
Our results on the effect of multiple preventable risk factors on
life expectancy disparities at the national level are supported by
those from analyses in specific cohorts, which were not nationally
representative. For example, in the Atherosclerosis Risk in
Communities (ARIC) Study, blacks and whites had nearly
identical CVD incidence rates after adjustment for smoking,
blood pressure, cholesterol and glucose [18]. Analyses of the
Multiple Risk Factor Intervention Trial found that adjustment for
major CVD risk factors reduced the differences in CVD mortality
although there was a statistically significant remaining difference
[19,20]. A recent reanalysis of the Whitehall follow-up study found
that interventions for the same risk factors as the ARIC study were
expected to reduce coronary heart disease mortality differentials
between occupational classes by 86% [46]. Finally, the Korean
Figure 2. Probability of death from different medical causes between 15 and 60 years of age (45Q15) and between 60 and 75 years
of age (15Q60) in the current and optimal distributions of risk factors in the Eight Americas in men. See definitions of the Eight Americas
in Table 1.
doi:10.1371/journal.pmed.1000248.g002
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study also found that absolute socioeconomic mortality inequalities
could be substantially reduced if either behavioral (smoking,
alcohol use, and physical inactivity) or metabolic risks (blood
pressure, fasting serum glucose, and serum total cholesterol) were
improved [47,48]. Some of these studies found larger effects of risk
factors on disparities that those in our analysis, possibly due to the
inclusion of other risks (e.g., lipids, physical inactivity) and
indicators such as income and education that either directly or
through other metabolic, dietary, and lifestyle factors affect
mortality disparities. National analysis in the US estimated that
58% of disparities in total mortality among young and middle-age
men was due to smoking; there also seems to be some effect of risk
factors on disparities in self-reported disease diagnoses and health
status (noting that self-reported health status is commonly
measured with bias, error, and incomparability) [21–23,49].
Beyond its innovation in assessing the effects of modifiable risk
factors on the national US life expectancy disparities, our analysis
has several strengths. Our PAF calculations incorporated multi-
causality and mediated effects, with parameters from systematic or
comprehensive reviews of epidemiologic studies. We calculated
PAFs for multiple risk factors using individual level exposure data,
thereby eliminating the need to parameterize the joint distribution
of risk factors and make strong assumptions about the shape of the
distributions and their correlations. Our outcome variables were
life expectancy and probabilities of death, which incorporate
competing risks from other diseases using life table methods.
Further, life tables were estimated separately for the Eight
Americas and by sex because they have distinct patterns of
competing risks. Finally, we quantified the uncertainty as a result
of the sampling variability in exposure, RRs, mediated effects of
BMI, and disease-specific mortality rates.
Population-level analyses like ours also have limitations. First,
the BRFSS does not provide data or indicators of sufficient detail
and quality on alcohol use, blood lipids, relevant dietary risk
factors (e.g., salt and various fats), and physical activity in the Eight
Americas. Therefore, these risk factors could not be included in
our analysis, even though they may have significant variation by
race and/or region [12,50–52]. Using NHANES 2003–2006 data
at the national level, the combined effects of LDL cholesterol and
the four risk factors in our analysis on life expectancy would be
0.1 y higher for men and women than that of these four risk
factors alone. The difference between the effects of the two clusters
of risk factors is small despite the fact that LDL cholesterol is an
important risk factor for CVD mortality; rather, because of
multicausality, the combined PAF for the effects of multiple risk
Figure 3. Probability of death from different medical causes between 15 and 60 years of age (45Q15) and between 60 and 75 years
of age (15Q60) in the current and optimal distributions of risk factors in the Eight Americas in women. See definitions of the Eight
Americas in Table 1.
doi:10.1371/journal.pmed.1000248.g003
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additional risk factor, even when its individual effect is relatively
large. Further, mean age-standardized LDL cholesterol among
blacks was only 1 mg/dl (,1%) higher than whites for men; black
women had lower cholesterol than whites by 7 mg/dl (,6%),
indicating that its contribution to disparities may be modest across
groups other than Asians. Harmful alcohol use is an important risk
factor for injuries and diseases such as cirrhosis, which had
substantial disparity in the Eight Americas [53].
The second limitation of our analysis arises from the fact that
the possibility of effect size modification by race cannot be ruled
out, even though the current evidence is generally consistent with
RRs being similar by race. RR differences may be especially
relevant for smoking, for which factors such as smoking intensity
and duration of smoking or smoking cessation may influence RRs.
Third, because BRFSS does not measure SBP, FPG, weight, and
height, we applied validated statistical models to NHANES and
BRFSS data to predict these variables and correct for bias in self-
reported data [14–16]. While this is an innovative use of multiple
data sources for subnational risk factor measurement, with
relatively high predictive power, it could use only those predictors
that were measured in NHANES and BRFSS using consistent or
comparable questionnaires. There was unexplained variation in
the model that could result in underestimating exposure variability
across the Eight Americas [15]. Hence our results should be
considered conservative estimates of the effects of risk factors on
mortality disparities. Further, these prediction models result in
additional uncertainty beyond sampling error, making the
reported uncertainty intervals in Figure 1 an underestimate of
the true uncertainty. Fourth, the combined effects of the four risk
factors included in our analysis may follow a model different
fromthat presented in Text S1. For example, a part of the effect of
smoking on cardiovascular diseases may be mediated through
blood pressure and/or glucose. A sensitivity analysis showed that
25% of the effects of smoking on cardiovascular outcomes were
mediated through these factors, our estimated effects on life-
expectancy levels and disparities would change by less than 0.06 y.
A key feature of our analysis is using the Eight Americas, which
are based on race, and on county location and socioeconomic
characteristics. As discussed in previous work [1,2], using county
and race–county combinations as units of analysis has allowed us
to examine mortality disparities in consistent, comparable, and
easily identifiable units over decades, but does not capture within-
county variations in risk factor exposure and mortality. Finally, we
could not include individuals with Hispanic ethnicity as a separate
America. Previous analyses have shown that Hispanic ethnicity is
significantly under-recorded on death certificates, leading to
implausibly high life expectancies when combined with population
estimates from census using self-reported Hispanic ethnicity
[54,55]. Future analyses should attempt to adjust for this mortality
undercount, or conduct analyses for Hispanics in regions where
mortality undercount is likely to be small, e.g., in states with large
Hispanic population [56].
Our results demonstrate that a small number of risk factors for
chronic diseases account for a noticeable part of the disparities in
life expectancy in the US, with the largest contributions from
smoking and high blood pressure. These disparity effects influence
young and middle-aged adults, as well as older adults, with the
largest effects on CVD, diabetes, and some cancers. The report of
the WHO Commission on Social Determinants of Health has
called attention to distribution of money, power, and resources as
the underlying sources of health disparities, but has also
emphasized the need to focus on common risk factors for chronic
diseases with known and effective interventions [57]. Similarly the
most recent House of Commons Health Committee Report in the
UK identified three groups of causes for health inequalities: access
to health care, socioeconomic factors, and lifestyle factors [58].
The essential question is therefore how to use disease prevention to
improve health and reduce health disparities together with policies
that aim to reduce socioeconomic disparities, reform health care,
and improve quality of care.
An essential first step in achieving the aggregate and disparity
promises of prevention is to discard a dominant view in the US
that behavioral, dietary, and metabolic risk factors are either
personal choices and responsibilities or are in the domain of
clinical practice and hence only a subject of health education and
physician advice for individuals. Rather, we must identify,
implement, and rigorously evaluate effective population-based
and personal interventions that can reduce these preventable risk
factors or mitigate their effects on disease outcomes (see, for
example, the reviews commissioned by the Robert Wood
Johnson Foundation on disparities in CVD and diabetes
[59,60]). Few or no current interventions have been effective in
reducing overweight and obesity at the population level,
emphasizing the need to develop and test new creative and
ambitious interventions. Diabetes prevention through lifestyle
and pharmacological interventions has been efficacious in trials
[61] but should be evaluated in community settings. Smoking
and blood pressure both have efficacious and cost-effective
interventions, and have successfully been lowered in the adult US
population as a whole for decades. These interventions need to
reach population subgroups and counties where smoking and
blood pressure remain high. Salt intake is an important predictor
of population blood pressure [62,63], and regulating and
reducing salt in prepared and packaged food is an effective
population-level intervention [64]; screening and use of antihy-
pertensives or combination therapy to reduce blood pressure and
cardiovascular risk is also cost-ef f e c t i v e[ 6 5 ]a n ds h o u l db es c a l e d
up as a part of expanding and improving primary care in the
context of US health reform. A recent systematic review of
smoking interventions hypothesized that population-level inter-
ventions have the potential to reduce disparities in smoking [66].
Yet in practice, US risk factor trends have at best had a mixed
performance in terms of reducing exposure disparities [17].
Therefore, both national versus local and aggregate versus
disparity effects should determine the design, implementation,
and evaluation of policies and programs that aim to reduce risk
factor exposure.
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Background. Life expectancy (a measure of longevity and
premature death) and overall health have increased steadily
in the United States over recent years. New drugs, new
medical technologies, and better disease prevention have all
helped Americans to lead longer, healthier lives. However,
even now, some Americans live much longer and much
healthier lives than others. Health disparities—differences in
how often certain diseases occur and cause death in groups
of people classified according to their ethnicity, geographical
location, sex, or age—are extremely large and persistent in
the US. On average, black men and women in the US live 6.3
and 4.5 years less, respectively, than their white counterparts;
the gap between life expectancy in the US counties with the
lowest and highest life expectancies is 18.4 years for men
and 14.3 years for women. Disparities in deaths (mortality)
from chronic diseases such as cardiovascular diseases (for
example, heart attacks and stroke), cancers, and diabetes are
known to be the main determinants of these life expectancy
disparities.
Why Was This Study Done? Preventable risk factors such
as smoking, high blood pressure, excessive body fat
(adiposity), and high blood sugar are responsible for many
thousands of deaths from chronic diseases. Exposure to
these risk factors varies widely by race, state of residence,
and socioeconomic status. However, the effects of these
observed disparities in exposure to modifiable risk factors on
US life expectancy disparities have only been examined in
selected groups of people and it is not known how multiple
modifiable risk factors affect US health disparities. A better
knowledge about how disparities in risk factor exposure
contribute to health disparities is needed to ensure that
prevention programs not only improve the average health
status but also reduce health disparities. In this study, the
researchers estimate the effects of smoking, high blood
pressure, high blood sugar, and adiposity on US life
expectancy and on disparities in life expectancy and
disease-specific deaths among the ‘‘Eight Americas,’’
population groups defined by race and by the location
and socioeconomic characteristics of their county of
residence.
What Did the Researchers Do and Find? The researchers
extracted data on exposure to these risk factors from US
national health surveys, information on deaths from different
diseases in 2005 from the US National Center for Health
Statistics, and estimates of how much each risk factor
increases the risk of death from each disease from published
studies. They then used modeling methods to estimate the
effects of risk factor exposure on death rates and life
expectancy. The Asian subgroup had the lowest adiposity,
blood sugar, and smoking rates, they report, and the three
white subgroups had the lowest blood pressure. Blood
pressure was highest in the three black subgroups, whereas
the other three risk factors were highest in Western Native
Americans, Southern rural blacks, and whites living in
Appalachia and the Mississippi Valley. The effects on life
expectancy of these factors were smallest in Asians and
largest in Southern rural blacks but, overall, these risk factors
reduced the life expectancy for men and women born in
2005 by 4.9 and 4.1 years, respectively. Other calculations
indicate that if these four risk factors were reduced to
optimal levels, disparities among the subgroups in deaths
from cardiovascular diseases and diabetes and from cancers
would be reduced by up to 80% and 50%, respectively.
What Do These Findings Mean? These findings suggest
that disparities in smoking, blood pressure, blood sugar, and
adiposity among US racial and geographical subgroups
explain a substantial proportion of the disparities in deaths
from cardiovascular diseases, diabetes, and cancers among
these subgroups. The disparities in risk factor exposure also
explain some of the disparities in life expectancy. The
remaining disparities in deaths and life expectancy could be
the result of preventable risk factors not included in this
study—one of its limitations is that it does not consider the
effect of dietary fat, alcohol use, and dietary salt, which are
major contributors to different diseases. Thus, suggest the
researchers, reduced exposure to preventable risk factors
through the implementation of relevant policies and
programs should reduce life expectancy and mortality
disparities in the US and yield health benefits at a national
scale.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000248.
N The US Centers for Disease Control and Prevention, the US
Office of Minority Health, and the US National Center on
Minority Health and Health Disparities all provide informa-
tion on health disparities in the US
N MedlinePlus provides links to information on health
disparities and on healthy living (in English and Spanish)
N The US Centers for Disease Control and Prevention
provides information on all aspects of healthy living
N The American Heart Association and the American Cancer
Society provide information on modifiable risk factors for
patients and caregivers
N Healthy People 2010 is a national framework designed to
improve the health of people living in the US
N The US National Health and Nutrition Examination Survey
(NHANES) and the Behavioral Risk Factor Surveillance
System (BRFSS) collect information on risk factor exposures
in the US
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